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Recent studies (1) have shown that ultrasound assessment of
left ventricular and arterial geometry can identify "preclinical" 
cardiovascular disease in asymptomatic hypertensive patients. 
Increased left ventricular mass predicts greater isk of cardio- 
vascular events, especially fatal ones, independently of arterial 
pressure, other risk factors or the presence of coronary artery 
disease (2-6). Further classification of hypertensive patients by 
their ventricular geometric patterns, including concentric or 
eccentric hypertrophy, concentric ventricular emodeling or 
normal geometry, identifies groups with distinctive pathophys- 
iologic patterns (7--10) and may add to ventricular mass for 
stratification of risk (3). In the present issue of the Journal 
there are two reports that examine the latter possibility (11,12). 
Why would left ventrieular geometric patterns predict differ- 
ent prognoses? Several studies (7-11,13,14) have assessed 
pathophysiologic features and therapeutic responsiveness of 
hypertensive patients classified by ventricular geometric pat- 
tern. Compared with patients with normal geometry, those 
with concentric hypertrophy orremodeling have higher arterial 
pressure, especially during ambulatory monitoring (7-8,11), 
associated with lower cardiac output, higher peripheral resis- 
tance and reduced plasma volume with concentric remodeling 
(13). Patients with concentric ventricular patterns also have 
lower myocardial function (10) and are more likely to be of 
African-American descent (15,16). Patients with increased 
ventricular mass have a higher cardiac output and relative body 
weight (7,9) and are more likely to have carotid artheroscle- 
rosis (17); those with eccentric hypertrophy may consume 
excessive dietary salt (18) and have expanded plasma volume 
(13). Patients with concentric hypertrophy have the greatest 
extracardiac vascular damage (9,19). 
These pathophysiologic profiles support he concept hat 
increased left ventricular mass is a "final common pathway" of 
many adverse ffects on the heart (1). The biologic differences 
among groups of patients with different ventricular geometries 
help explain the finding by Verdecchia et al. (11), Krumholz et 
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al. (12) and previous investigators (3,20) that morbid events 
are as much as four timely more likely to occur in subjects with 
concentric hypertrophy than in those with normal ventricular 
geometry. However, these same data also suggest that at least 
part of the prognostic significance of ventricular geometric 
patterns is due to the abnormalities with which they are 
associated (12). Some of these abnormalities are readily acces- 
sible, including clinical blood pressure, relative body weight 
and cholesterol and creatinine levels. However, higher ambu- 
latory blood pressure, peripheral resistance, salt intake, urinary 
albumin excretion and the presence of atherosclerosis are not 
so readily detected. 
Do the present studies refine our understanding? Verdec- 
chia et al. (11) in this issue of the Journal relate baseline 
findings to incident morbid events during a follow-up of up to 
7 years in 694 hypertensive patients in whom initial echocar- 
diography revealed either normal eft ventricular geometry or 
concentric remodeling on the basis of prognostically validated 
partition values for ventricular mass (125 g/m 2) and relative 
wall thickness (0.45). The groups were similar in age, gender, 
degree of overweight, funduscopic findings and serum glucose, 
creatinine and cholesterol levels, but those with concentric 
remodeling had slightly higher blood pressure in the clinic 
during daytime hours and during the entire 24 h. The incidence 
of morbid events was 2.39 and 1.12/100 patients-years in those 
with and without concentric ventricular remodeling, yielding a 
crude odds ratio of 2.28. Adjustment for age, gender, clinical 
and ambulatory blood pressure, diabetes and left ventricular 
mass index in multivariate analysis actually slightly increased 
the odds ratio to 2.56 for morbid events associated with the 
presence of concentric ventricular remodeling. 
One must be cautious in interpreting results based on the 
small number of events (29 in 694 patients) and lack of analysis 
of cigarette smoking (11). Although in the study by Verdecchia 
et al. (11), patients with concentric left ventricular remodeling 
had slightly higher ventricular mass than those with normal eft 
ventricular geometry, as previously reported (9), adjustment 
for this difference in ventricular mass within the normal range 
did not lessen the adverse prognostic impact of concentric 
ventricular remodeling. 
The parallel study by Krumholz et al. (12), also in this issue 
of the Journal, has the potential to be more definitive because 
of its large number of subjects (n = 3,216) and end points (399 
cardiovascular events and 259 deaths of all causes). During an 
8-year follow-up, stepwise increases in event rates from low 
risk subjects with normal geometry to intermediate risk groups 
with concentric remodeling or eccentric hypertrophy to the 
high risk group with concentric hypertrophy were observed for 
all cardiovascular events (9.5% to 16.3% and 29%) and for 
all-cause mortality (6% to 13%, 11% and 22%). These event 
rates closely resemble those reported by Koren et al. (3), 
Mensah et al. (20) and de Simone et al. (10). However, 
consideration of eight conventional risk factors as covariates 
reduced the odds ratios for cardiovascular events and all-cause 
mortality associated with concentric left ventricular remodel- 
©1995 by the American College of Cardiolo D' 0735-1097/95/$9.50 
0735-1097(94)00547-4 
886 DEVEREUX JACC Vol. 25, No. 4 
EDITORIAL COMMENT March 15, 1995:885-7 
ing and eccentric or concentric hypertrophy to 1.0 to 2.1 and 
1.3 to 2.1, respectively, in men. In women, this adjustment 
reduced the odds ratios associated with abnormal left ventric- 
ular geometries to 1.3 to 1.5 for all-cause mortality. When 
ventricular mass indexed for body weight was added as a 
covariate (12), odds ratios for cardiovascular events associated 
with ventricular geometric abnormalities were 0.8 to 1.3 among 
men and 1.2 to 1.3 among women, whereas those for all-cause 
mortality were to 1.2 to 1.7 among men and i. 1 among women. 
At first glance, these results suggest hat ventricular geo- 
metric patterns carry no prognostic significance once conven- 
tional risk factors and ventricular muscle mass are taken into 
account. However, it is impossible to discern many of the 
relations of primary importance to multivariate analyses be- 
cause demographic, body habitus and risk factor data are 
presented for women and men but not for subjects classified by 
ventricular geometric patterns. Lack of data for the ->75 
cardiovascular deaths that would have been expected isdisap- 
pointing because this outcome has been specifically related to 
left ventricular geometry in previous tudies (3,4). The presen- 
tation of left ventricular mass indexed for height but neither 
unindexed nor indexed for body surface area limits comparison 
of this report (12) to studies from other centers. Additionally, 
because the indexation of ventricular mass for height was 
chosen because of its positive relation to body mass index in 
this population (21), adjustment ofresults for body mass index 
may have understated ventricular mass effects in multivariate 
analyses. Finally, adjustment of the predictive value of ventric- 
ular geometric classification for the observed value of ventric- 
ular mass is of conceptual concern. 
The implications of this analytic approach may be appreci- 
ated by considering the fundamental interrelationships among 
chamber size, relative wall thickness and mass. As may be seen 
in Figure 1, increasing ventricular internal dimension and 
relative wall thickness exert multiplicative ffects on left ven- 
tricular mass, represented by the curved isomass lines. The 
arrows at the top of Figure 1 indicate the directions of 
geometric changes induced by pure pressure or volume over- 
load or by ventricular dysfunction (22-24). Because classifica- 
tion of ventricular geometric patterns relies on the relation of 
ventricular mass to relative wall thickness, holding ventricular 
mass constant by adjusting for it in multivariate analyses 
requires that as relative wall thickness increases, ventricular 
chamber size must decrease (arrows along the ventricular 
isomass lines in Figure 1). Therefore, the final adjustment 
performed by Krumholz et al. (12) would decrease the risk 
associated with a high relative wall thickness unless a worse 
prognosis were associated with smaller ventricular chamber 
size. However, several causes of ventricular enlargement i  the 
general population (obesity, excess alt intake, asymptomatic 
ventricular dysfunction, regurgitant valvular disease without a 
grade 3/6 murmur and mild renal dysfunction) may be associ- 
ated with an adverse prognosis. Thus, the final adjustment by 
Krumholz et al. may be biologically incorrect. 
Clinical implications. Although final conclusions cannot 
yet be reached, the reports from outstanding investigative 
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Figure 1. Relation of left ventricular (LV) isomass lines representing 
(from bottom to top) 120, 160, 200, 240 and 280 g with left ventricular 
relative wall thickness (horizontal axis) and end-diastolic internal 
dimension (vertical axis). Stippled band represents he range of 
indexed left ventricular mass partition values predictive of adverse 
outcome (116 to 125 g/m 2 in references 2 and 3) for an adult of average 
body surface area (1.78 me). Arrows in upper right-hand portion 
indicate direction of left ventricular geometric deviations produced 
when left ventricular hypertrophy is induced by pure pressure or 
volume overload or contractile dysfunction. 
groups in this issue of the Journal (11,12) support a strong 
relationship of left ventricular geometric pattern to morbidity 
and mortality. The results of Verdecchia et al. (11) and of 
previous tudies (3,20) suggest hat risk stratification by char- 
acterization of ventricular geometry is largely independent of
conventional risk factors. However, the report by Krumholz et 
al. (12) highlights the need to evaluate further the indepen- 
dence from easily measurable variables of the ability of left 
ventricular geometry and other indexes of preclinical disease 
(1) to predict prognosis. In the meantime, for patients to 
benefit from the ability to identify as much as a fourfold 
difference in risk between those with normal geometry and 
concentric hypertrophy, meticulous attention to technique in 
performance and standardization of echocardiography is 
needed (25,26). 
I thank Drs. Giovanni de Simone and Mary J. Roman for their critical reading 
of the manuscript and Virginia Burns and Patricia Hilzinger for their assistance 
in its preparation. 
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